Somatostatin analogue microspheres

Somatostain analogues are used to treat acromegaly and growth hormone dependent cancers. Since somatostatin has a short half life, it needs to be administered 3-4 times per day. Our scientists have created a 1 month long single injection that offers tailored release of the drug.

Our process of manufacturing microspheres is cleaner compared to the other products available in the market which uses class 2 solvents in large quantities.

A Phase III study in acromegaly patients has been completed with satisfactory results, and a brand has been launched in India. Activities are ongoing for an IND filing of this product in US.

A similar product designed to release the drug over a three month period is currently under development and is expected to greatly enhance patient compliance.

A few CNS agents are also being investigated as injectable depot systems.